Skip to main content
OpenTrials

Clinical trial condition

Synostosis

Explore clinical trials studying Synostosis. Study availability and eligibility vary by location and protocol.

66 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Synostosis trial results

Completed

A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene Fusion

NCT04238715

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +16 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Beijing Tsinghua Chang Gung Memorial Hospital Beijing, Beijing Municipality, China
  • Beijing Youan Hospital Affiliated to Capital Medical University Beijing, Beijing Municipality, China
View all 56 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

NCT02872714

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Arizona Oncology Associates (Wilmot) Tucson, Arizona, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • UCSF Helen Diller Family Comprehensive Care Center San Francisco, California, United States
  • Rocky Mountain Cancer Centers Boulder, Colorado, United States
View all 96 locations
View Trial Details
Completed

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

NCT05253807

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Florida Cancer Specialists & Research Institute Fort Myers, Florida, United States
  • Miami Cancer Institute Miami, Florida, United States
  • Memorial Healthcare System Pembroke Pines, Florida, United States
View all 36 locations
View Trial Details
Completed

A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma

NCT02699606

Conditions
Acrocephalosyndactylia, Adenocarcinoma, Bone Diseases, +33 more
Locations
  • Beijing, China
  • Harbin, China
  • Nanjing, China
  • Seoul, South Korea
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma

NCT01703481

Conditions
Acrocephalosyndactylia, Bone Diseases, Bone Diseases, Developmental, +29 more
Locations
  • Birmingham, Alabama, United States
  • Tucson, Arizona, United States
  • La Jolla, California, United States
  • Los Angeles, California, United States
View all 37 locations
View Trial Details

Related conditions